Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocata Therapeutics Inc (NASDAQ:OCAT)

4.16
Delayed Data
As of Aug 04
 -0.19 / -4.37%
Today’s Change
3.55
Today|||52-Week Range
12.73
-31.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues506.4K466.5K225.0K157.9K
 
 
 
 
 
Cost of Goods Sold276.8K58.8K39.9K62.4K
 
 
 
 
 
Depreciation And Amortization67.2K58.6K93.5K173.1K
 
 
 
 
 
 
Operating ExpensesGross Income162.5K349.1K91.5K-77.6K
 
 
 
 
 
General Expenses21.0M21.8M24.6M21.4M
 
 
 
 
 
Research And Development10.0M11.4M11.7M10.5M
 
 
 
 
 
Total Operating Expenses21.4M21.9M24.7M21.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.9M-21.5M-24.5M-21.5M
 
 
 
 
 
Extraordinary Credit11.4M889.9K1.7M762.9K
 
 
 
 
 
Extraordinary Charge-294.1K-7.2M-7.1M-13.6M
 
 
 
 
 
Interest Expense On Debt1.5M1.1M1.4M429.6K
 
 
 
 
 
Equity In Earnings-820.0K0.000.00--
 
 
Other Expenses-60.8M-17.1K160.1K-10.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-72.0M-28.5M-31.0M-34.7M
 
 
 
 
 
Preferred Dividend0.000.000.00-1.9M
 
 
Net Income-72.8M-28.5M-31.0M-34.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.8M20.9M24.9M31.3M
 
 
 
 
 
Shares To Calculate EPS Diluted15.8M20.9M24.9M31.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.00-$1.00-$1.00-$1.17
 
 
 
 
 
EPS Diluted-$5.00-$1.00-$1.00-$1.17